A paediatric canopy system for aerosol administration and minimized environmental pollution

Area of Science:

• Pediatric respiratory care
• Medical device engineering
• Pharmacokinetics

Background:

• Developed a novel canopy system for ribavirin aerosol administration to infants.
• Aimed to enhance treatment control, infant accessibility, and reduce environmental contamination.
• System designed with sealable apertures and a specific gas flow to prevent aerosol leakage.

Purpose of the Study:

• Evaluate the stability of physical variables (temperature, humidity, CO2) within the canopy.
• Assess the impact of infant body weight on these variables.
• Determine the safety and efficacy of the canopy system in a clinical and laboratory setting.

Main Methods:

• Clinical evaluation: 10 infants (1.8-7.1 kg) in canopy for 1 hour; measured internal physical variables and infant physiological responses (body temp, skin temp, respiratory rate).
• Laboratory evaluation: Assessed aerosol leakage using smoke tests and ambient air admixture; measured sound levels.
• Statistical analysis to correlate variables with infant body weight.

Main Results:

• Stable canopy environment: Temperature (25.1-29.6°C), relative humidity (52-88%), and sound level (52 dBA).
• Carbon dioxide concentration (1000-3900 PPM) and temperature correlated with infant body weight (P < 0.001, P < 0.05).
• No significant influence on infant body temperature; respiratory rate decreased by 13% (P < 0.01); no aerosol leakage observed.

Conclusions:

• The canopy system provides controlled aerosol therapy with excellent infant visibility and accessibility.
• It minimizes environmental pollution and maintains a comfortable physical environment.
• No apparent risks of CO2 rebreathing or cooling stress were identified for infants within the specified weight range.